✦ LIBER ✦

PUK1 THE COST-EFFECTIVENESS OF EXTENDED RELEASE TOLTERODINE IN THE MANAGEMENT OF OVERACTIVE BLADDER IN GERMANY AND THE UNITED KINGDOM

✍ Scribed by P Anderson; A Resch; JA Dooley; B Brüggenjürgen; G Zlateva

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK2 COST-EFFECTIVENESS ANALYSIS OF EXTE

✍ D Castro; J Soto; I Exposito 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PUK14 Cost-Effectiveness Analysis of Mir

✍ J. Xie; Z.Y. Zhou; C.N. Bui; Y. Yan; G. De; M.C. Runken; E.Q. Wu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PUK20 A COST EFFECTIVENESS ANALYSIS OF S

✍ HH Kang; JY Bae; SY Park; HS Sohn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PUK9 COST OF OVERACTIVE BLADDER IN THE U

✍ ML Ganz; AM Smalarz; JT Anger; TL Krupski; JC Hu; KU Wittrup-Jensen; CL Pashos 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The cost-effectiveness of solifenacin vs

✍ Linda Cardozo; Andrew Thorpe; Juliet Warner; Manpreet Sidhu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB